Hubei Guangji Pharmaceutical Co Ltd (000952) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Hubei Guangji Pharmaceutical Co Ltd (000952) has a cash flow conversion efficiency ratio of 0.023x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥22.38 Million ≈ $3.27 Million USD) by net assets (CN¥963.20 Million ≈ $140.95 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Hubei Guangji Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
Hubei Guangji Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)
This chart illustrates how Hubei Guangji Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 000952 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Hubei Guangji Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Hubei Guangji Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Western Power Industrial Co Ltd
SHE:002630
|
0.072x |
|
Anora Group Oyj
HE:ANORA
|
0.266x |
|
Jasmine International Public Company Limited
BK:JAS
|
0.020x |
|
Daishin Securities Co Ltd Pref
KO:003545
|
-0.259x |
|
Nongshim Holdi
KO:072710
|
0.015x |
|
Career Technology MFG Co Ltd
TW:6153
|
-0.028x |
|
Parrot
PA:PARRO
|
0.198x |
|
Qudian Inc
NYSE:QD
|
0.053x |
Annual Cash Flow Conversion Efficiency for Hubei Guangji Pharmaceutical Co Ltd (1998–2025)
The table below shows the annual cash flow conversion efficiency of Hubei Guangji Pharmaceutical Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 000952 market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥626.85 Million ≈ $91.73 Million |
CN¥60.43 Million ≈ $8.84 Million |
0.096x | +15730.22% |
| 2024-12-31 | CN¥1.08 Billion ≈ $157.48 Million |
CN¥655.36K ≈ $95.90K |
0.001x | +100.57% |
| 2023-12-31 | CN¥1.39 Billion ≈ $203.76 Million |
CN¥-148.96 Million ≈ $-21.80 Million |
-0.107x | -454.02% |
| 2022-12-31 | CN¥1.49 Billion ≈ $218.30 Million |
CN¥45.08 Million ≈ $6.60 Million |
0.030x | -42.24% |
| 2021-12-31 | CN¥1.45 Billion ≈ $212.30 Million |
CN¥75.91 Million ≈ $11.11 Million |
0.052x | -40.15% |
| 2020-12-31 | CN¥1.37 Billion ≈ $199.84 Million |
CN¥119.38 Million ≈ $17.47 Million |
0.087x | -41.54% |
| 2019-12-31 | CN¥964.30 Million ≈ $141.11 Million |
CN¥144.20 Million ≈ $21.10 Million |
0.150x | -43.08% |
| 2018-12-31 | CN¥880.96 Million ≈ $128.91 Million |
CN¥231.44 Million ≈ $33.87 Million |
0.263x | +12.42% |
| 2017-12-31 | CN¥765.24 Million ≈ $111.98 Million |
CN¥178.83 Million ≈ $26.17 Million |
0.234x | -7.80% |
| 2016-12-31 | CN¥659.18 Million ≈ $96.46 Million |
CN¥167.07 Million ≈ $24.45 Million |
0.253x | +490.58% |
| 2015-12-31 | CN¥513.86 Million ≈ $75.19 Million |
CN¥-33.35 Million ≈ $-4.88 Million |
-0.065x | +56.09% |
| 2014-12-31 | CN¥505.45 Million ≈ $73.96 Million |
CN¥-74.69 Million ≈ $-10.93 Million |
-0.148x | -214.15% |
| 2013-12-31 | CN¥735.04 Million ≈ $107.56 Million |
CN¥95.16 Million ≈ $13.92 Million |
0.129x | -8.91% |
| 2012-12-31 | CN¥760.05 Million ≈ $111.22 Million |
CN¥108.02 Million ≈ $15.81 Million |
0.142x | +49.90% |
| 2011-12-31 | CN¥863.60 Million ≈ $126.37 Million |
CN¥81.88 Million ≈ $11.98 Million |
0.095x | +3.11% |
| 2010-12-31 | CN¥839.35 Million ≈ $122.82 Million |
CN¥77.18 Million ≈ $11.29 Million |
0.092x | +408.50% |
| 2009-12-31 | CN¥816.91 Million ≈ $119.54 Million |
CN¥-24.35 Million ≈ $-3.56 Million |
-0.030x | -110.96% |
| 2008-12-31 | CN¥811.28 Million ≈ $118.72 Million |
CN¥220.70 Million ≈ $32.30 Million |
0.272x | -44.85% |
| 2007-12-31 | CN¥673.00 Million ≈ $98.48 Million |
CN¥331.98 Million ≈ $48.58 Million |
0.493x | +87.08% |
| 2006-12-31 | CN¥477.68 Million ≈ $69.90 Million |
CN¥125.95 Million ≈ $18.43 Million |
0.264x | +158.99% |
| 2005-12-31 | CN¥531.76 Million ≈ $77.81 Million |
CN¥54.14 Million ≈ $7.92 Million |
0.102x | +1705.73% |
| 2004-12-31 | CN¥523.19 Million ≈ $76.56 Million |
CN¥-3.32 Million ≈ $-485.42K |
-0.006x | +78.81% |
| 2003-12-31 | CN¥514.56 Million ≈ $75.30 Million |
CN¥-15.40 Million ≈ $-2.25 Million |
-0.030x | -119.91% |
| 2002-12-31 | CN¥506.86 Million ≈ $74.17 Million |
CN¥76.20 Million ≈ $11.15 Million |
0.150x | +426.75% |
| 2001-12-31 | CN¥486.87 Million ≈ $71.24 Million |
CN¥-22.40 Million ≈ $-3.28 Million |
-0.046x | -145.62% |
| 2000-12-31 | CN¥481.54 Million ≈ $70.46 Million |
CN¥48.57 Million ≈ $7.11 Million |
0.101x | -33.92% |
| 1999-12-31 | CN¥449.30 Million ≈ $65.75 Million |
CN¥68.57 Million ≈ $10.03 Million |
0.153x | +291.61% |
| 1998-12-31 | CN¥191.95 Million ≈ $28.09 Million |
CN¥-15.29 Million ≈ $-2.24 Million |
-0.080x | -- |
About Hubei Guangji Pharmaceutical Co Ltd
Hubei Guangji Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical raw materials, pharmaceutical preparations, and feed additives in China and internationally. It also exports its products. The company was founded in 1969 and is based in Wuxue, China.